Group One Trading, L.P. Forte Biosciences, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 14,017 shares of FBRX stock, worth $65,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,017
Previous 14,527
3.51%
Holding current value
$65,599
Previous $10,000
30.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding FBRX
# of Institutions
29Shares Held
17.3MCall Options Held
3.1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$17 Million0.49% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$15.3 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$14 Million0.05% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$9.51 Million1.15% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$8.61 Million0.0% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $95.2M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.